Logo image of IFX.CA

IMAFLEX INC (IFX.CA) Stock Fundamental Analysis

Canada - TSX-V:IFX - CA4524352099 - Common Stock

1.13 CAD
+0.02 (+1.8%)
Last: 9/26/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to IFX. IFX was compared to 8 industry peers in the Containers & Packaging industry. IFX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. IFX scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year IFX was profitable.
In the past year IFX had a positive cash flow from operations.
In the past 5 years IFX has always been profitable.
In the past 5 years IFX always reported a positive cash flow from operatings.
IFX.CA Yearly Net Income VS EBIT VS OCF VS FCFIFX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

1.2 Ratios

IFX has a worse Return On Assets (2.51%) than 62.50% of its industry peers.
Looking at the Return On Equity, with a value of 3.52%, IFX is doing worse than 62.50% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 5.57%, IFX is doing worse than 62.50% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for IFX is in line with the industry average of 7.91%.
Industry RankSector Rank
ROA 2.51%
ROE 3.52%
ROIC 5.57%
ROA(3y)7.21%
ROA(5y)9.25%
ROE(3y)9.67%
ROE(5y)13.04%
ROIC(3y)7.65%
ROIC(5y)10.7%
IFX.CA Yearly ROA, ROE, ROICIFX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

IFX has a Profit Margin of 2.06%. This is in the lower half of the industry: IFX underperforms 62.50% of its industry peers.
IFX's Profit Margin has improved in the last couple of years.
IFX has a Operating Margin of 5.03%. This is in the lower half of the industry: IFX underperforms 75.00% of its industry peers.
In the last couple of years the Operating Margin of IFX has grown nicely.
IFX's Gross Margin of 14.65% is on the low side compared to the rest of the industry. IFX is outperformed by 75.00% of its industry peers.
In the last couple of years the Gross Margin of IFX has grown nicely.
Industry RankSector Rank
OM 5.03%
PM (TTM) 2.06%
GM 14.65%
OM growth 3Y-10.09%
OM growth 5Y7.97%
PM growth 3Y-4.44%
PM growth 5Y29.09%
GM growth 3Y0.33%
GM growth 5Y3.9%
IFX.CA Yearly Profit, Operating, Gross MarginsIFX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IFX is destroying value.
Compared to 1 year ago, IFX has about the same amount of shares outstanding.
IFX has more shares outstanding than it did 5 years ago.
IFX has a better debt/assets ratio than last year.
IFX.CA Yearly Shares OutstandingIFX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
IFX.CA Yearly Total Debt VS Total AssetsIFX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

IFX has an Altman-Z score of 3.88. This indicates that IFX is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 3.88, IFX belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
IFX has a debt to FCF ratio of 0.68. This is a very positive value and a sign of high solvency as it would only need 0.68 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.68, IFX belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
IFX has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
IFX has a better Debt to Equity ratio (0.11) than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 0.68
Altman-Z 3.88
ROIC/WACC0.66
WACC8.41%
IFX.CA Yearly LT Debt VS Equity VS FCFIFX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

IFX has a Current Ratio of 2.51. This indicates that IFX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.51, IFX is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
IFX has a Quick Ratio of 1.69. This is a normal value and indicates that IFX is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of IFX (1.69) is better than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.51
Quick Ratio 1.69
IFX.CA Yearly Current Assets VS Current LiabilitesIFX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

6

3. Growth

3.1 Past

The earnings per share for IFX have decreased strongly by -49.23% in the last year.
The Earnings Per Share has been growing by 36.43% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 6.69% in the past year.
IFX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.26% yearly.
EPS 1Y (TTM)-49.23%
EPS 3Y-4.09%
EPS 5Y36.43%
EPS Q2Q%-105.77%
Revenue 1Y (TTM)6.69%
Revenue growth 3Y0.73%
Revenue growth 5Y6.26%
Sales Q2Q%-8.45%

3.2 Future

IFX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 130.94% yearly.
Based on estimates for the next years, IFX will show a quite strong growth in Revenue. The Revenue will grow by 13.35% on average per year.
EPS Next Y366.67%
EPS Next 2Y130.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.85%
Revenue Next 2Y13.35%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IFX.CA Yearly Revenue VS EstimatesIFX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
IFX.CA Yearly EPS VS EstimatesIFX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15 0.2

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 28.25 indicates a quite expensive valuation of IFX.
Compared to the rest of the industry, the Price/Earnings ratio of IFX indicates a slightly more expensive valuation: IFX is more expensive than 75.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of IFX to the average of the S&P500 Index (27.32), we can say IFX is valued inline with the index average.
IFX is valuated cheaply with a Price/Forward Earnings ratio of 6.86.
100.00% of the companies in the same industry are more expensive than IFX, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.89, IFX is valued rather cheaply.
Industry RankSector Rank
PE 28.25
Fwd PE 6.86
IFX.CA Price Earnings VS Forward Price EarningsIFX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IFX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IFX indicates a rather cheap valuation: IFX is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.44
EV/EBITDA 5.11
IFX.CA Per share dataIFX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as IFX's earnings are expected to grow with 130.94% in the coming years.
PEG (NY)0.08
PEG (5Y)0.78
EPS Next 2Y130.94%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

IFX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

IMAFLEX INC

TSX-V:IFX (9/26/2025, 7:00:00 PM)

1.13

+0.02 (+1.8%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)08-28 2025-08-28/bmo
Earnings (Next)11-26 2025-11-26
Inst Owners10.17%
Inst Owner ChangeN/A
Ins Owners43.18%
Ins Owner ChangeN/A
Market Cap58.86M
Analysts84.44
Price Target2.04 (80.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-75.73%
Min EPS beat(2)-100%
Max EPS beat(2)-51.46%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-10.83%
Min Revenue beat(2)-16.54%
Max Revenue beat(2)-5.12%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)180%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.92%
Valuation
Industry RankSector Rank
PE 28.25
Fwd PE 6.86
P/S 0.54
P/FCF 4.44
P/OCF 3.54
P/B 0.92
P/tB 0.96
EV/EBITDA 5.11
EPS(TTM)0.04
EY3.54%
EPS(NY)0.16
Fwd EY14.58%
FCF(TTM)0.25
FCFY22.51%
OCF(TTM)0.32
OCFY28.28%
SpS2.09
BVpS1.23
TBVpS1.18
PEG (NY)0.08
PEG (5Y)0.78
Profitability
Industry RankSector Rank
ROA 2.51%
ROE 3.52%
ROCE 7.46%
ROIC 5.57%
ROICexc 6.52%
ROICexgc 6.77%
OM 5.03%
PM (TTM) 2.06%
GM 14.65%
FCFM 12.16%
ROA(3y)7.21%
ROA(5y)9.25%
ROE(3y)9.67%
ROE(5y)13.04%
ROIC(3y)7.65%
ROIC(5y)10.7%
ROICexc(3y)8.55%
ROICexc(5y)12.05%
ROICexgc(3y)8.89%
ROICexgc(5y)12.53%
ROCE(3y)10.53%
ROCE(5y)14.7%
ROICexcg growth 3Y-20.84%
ROICexcg growth 5Y5.88%
ROICexc growth 3Y-20.69%
ROICexc growth 5Y5.71%
OM growth 3Y-10.09%
OM growth 5Y7.97%
PM growth 3Y-4.44%
PM growth 5Y29.09%
GM growth 3Y0.33%
GM growth 5Y3.9%
F-Score6
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 0.68
Debt/EBITDA 0.61
Cap/Depr 59.72%
Cap/Sales 3.12%
Interest Coverage 8.96
Cash Conversion 149.13%
Profit Quality 589.96%
Current Ratio 2.51
Quick Ratio 1.69
Altman-Z 3.88
F-Score6
WACC8.41%
ROIC/WACC0.66
Cap/Depr(3y)236.8%
Cap/Depr(5y)164.27%
Cap/Sales(3y)10.14%
Cap/Sales(5y)6.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.23%
EPS 3Y-4.09%
EPS 5Y36.43%
EPS Q2Q%-105.77%
EPS Next Y366.67%
EPS Next 2Y130.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.69%
Revenue growth 3Y0.73%
Revenue growth 5Y6.26%
Sales Q2Q%-8.45%
Revenue Next Year22.85%
Revenue Next 2Y13.35%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.17%
EBIT growth 3Y-9.43%
EBIT growth 5Y14.73%
EBIT Next Year110.76%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1195.21%
FCF growth 3Y29.22%
FCF growth 5Y23.11%
OCF growth 1Y39.55%
OCF growth 3Y25.19%
OCF growth 5Y10.31%